Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1982
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
C08DB01
|
| gptkbp:contraindication |
gptkb:sick_sinus_syndrome
gptkb:second-_or_third-degree_AV_block severe hypotension |
| gptkbp:drugClass |
beta blocker
|
| gptkbp:eliminatedIn |
urine
|
| gptkbp:form |
gptkb:tablet
injection extended-release tablet |
| gptkbp:genericName |
diltiazem
|
| gptkbp:halfLife |
3-4.5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cardizem
|
| gptkbp:interactsWith |
gptkb:cyclosporine
gptkb:carbamazepine gptkb:digoxin beta blockers statins |
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Sanofi-Aventis
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
edema
dizziness headache bradycardia |
| gptkbp:usedFor |
gptkb:atrial_fibrillation
hypertension angina |
| gptkbp:bfsParent |
gptkb:Marion_Merrell_Dow
|
| gptkbp:bfsLayer |
7
|